Viewing nowGlymepride Tablets 2mg (Glymepride)
Glimepiride 2mg
Tablet · Prescription medication
Geonil Biopharm Co., Ltd.

MFDS item code 202001769 · Approved 2020.03.13 · Insurance code 073001150
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in combination with dietary and exercise therapy to assist in blood sugar control for patients with type 2 diabetes. If blood sugar control is insufficient, it can be administered alone or in conjunction with oral hypoglycemic agents or insulin. Particularly, when there is no effect from sulfonylureas or monotherapy with metformin, this medication can be used in combination with metformin for more effective blood sugar control. Thus, the appropriate administration method is selected based on the patient's condition to improve blood sugar regulation.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Administer this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with increases to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral antihyperglycemic medicine to this medicine There is no precise dose-equivalence relationship between this medicine and other oral antihyperglycemic medicines. When switching to this medicine from another oral antihyperglycemic medicine, it is advisable to follow the method described under Initial dose. That is, initiate treatment with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medicine. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. Hypoglycemia is generally controlled promptly by immediate intake of sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even if it was successfully managed initially. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may be increased. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes or those in diabetic ketoacidosis or coma. Additionally, individuals allergic to this medication or its components, those with severe liver or kidney dysfunction, and women who are pregnant or breastfeeding should not take this medication. In cases of severe infection, pre- and post-surgery, or significant trauma, insulin therapy is recommended instead of this medication. Caution should be exercised during gastrointestinal disorders such as diarrhea or vomiting, as poor food absorption may increase the risk of hypoglycemia. Individuals with genetically predisposed lactose intolerance should not take this medication due to the lactose it contains. During the early stages of treatment, the risk of hypoglycemia is high, so elderly patients, those with poor nutritional status, or those who eat irregularly, and individuals who frequently consume alcohol should monitor their blood sugar levels regularly. Individuals with reduced kidney or liver function may also respond more sensitively to this medication, requiring dose adjustments. Furthermore, coexisting endocrine disorders or concurrent use of multiple medications may increase the risk of hypoglycemia, so caution is necessary. This medication can induce hypoglycemic symptoms due to its blood sugar-lowering action, which may present as headaches, severe hunger, dizziness, confusion, drowsiness, and in severe cases, loss of consciousness. If hypoglycemia occurs, ingesting food or drinks containing sugar should quickly raise blood sugar levels, and it is advisable to always carry sugar with you. Transient visual blurriness, gastrointestinal disturbances, abnormal liver function, changes in blood cell counts, and allergic reactions may rarely occur, so any abnormal symptoms should be immediately consulted with a healthcare professional. It is essential to take this medication regularly and follow a dietary and exercise regimen for optimal blood sugar control. During treatment, regular monitoring of blood glucose and urine glucose, as well as liver function, is necessary to check for drug efficacy and side effects. Particularly, during driving or operating machinery, there is a risk of decreased concentration or behavioral disturbances due to hypoglycemia, so caution is warranted. This medication may interact with various other drugs, so if you are taking other medications, it is essential to inform your doctor or pharmacist. During pregnancy or breastfeeding, it is recommended to use insulin therapy instead of this medication since it may affect the fetus or newborn. The safety of this medication in children under 18 has not been established, and care should be taken with dosage adjustments in the elderly due to possible decreased kidney function. In case of overdose, severe hypoglycemia may occur, and immediate treatment should be sought at a hospital.
hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, anemia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, difficulty breathing, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disturbance, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature to preserve the medication's efficacy and safety for an extended period.
Green rectangular tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Geonil Biopharm Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.